Pasithea Therapeutics Corp.(KTTA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KTTA Pasithea Therapeutics Corp.

盘后交易 12-05 16:55:01 EST

1.13

-0.03

-2.59%

盘后1.11

-0.02-1.77%

16:54 EST

最高1.21	最低1.12	成交量126.60万
今开1.14	昨收1.16	日振幅7.76%
总市值841.13万	流通市值828.43万	总股本744.36万
成交额147.97万	换手率17.27%	流通股本733.12万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KTTA","market":"US","secType":"STK","nameCN":"Pasithea Therapeutics Corp.","latestPrice":1.13,"timestamp":1764968400000,"preClose":1.16,"halted":0,"volume":1266010,"hourTrading":{"tag":"盘后","latestPrice":1.11,"preClose":1.13,"latestTime":"16:54 EST","volume":5884,"amount":6739.542426,"timestamp":1764971679916},"delay":0,"floatShares":7331217,"shares":7443600,"eps":-3.25013,"marketStatus":"盘后交易","change":-0.03,"latestTime":"12-05 16:55:01 EST","open":1.14,"high":1.21,"low":1.12,"amount":1479731.351549,"amplitude":0.077586,"askPrice":1.15,"askSize":888,"bidPrice":1.11,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-3.25013,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1764982800000},"marketStatusCode":4,"adr":0,"listingDate":1628654400000,"exchange":"NASDAQ","adjPreClose":1.16,"preHourTrading":{"tag":"盘前","latestPrice":1.114,"preClose":1.16,"latestTime":"09:28 EST","volume":73035,"amount":85267.5810255,"timestamp":1764944933348},"postHourTrading":{"tag":"盘后","latestPrice":1.11,"preClose":1.13,"latestTime":"16:54 EST","volume":5884,"amount":6739.542426,"timestamp":1764971679916},"volumeRatio":0.034596},"requestUrl":"/m/hq/s/KTTA","defaultTab":"news","newsList":[{"id":"1101274106","title":"Form 4 | Pasithea Therapeutics Corp.董事 Lawrence Steinman 增持133,333股","url":"https://stock-news.laohu8.com/highlight/detail?id=1101274106","media":"老虎公告助手","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101274106?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:10","pubTimestamp":1764598216,"startTime":"0","endTime":"0","summary":"Pasithea Therapeutics Corp. (股票代码: KTTA) 的董事 Lawrence Steinman 于2025年11月28日增持了133,333股普通股票，交易价格为每股0.75美元，交易完成后，Lawrence Steinman持有199,691股普通股票。高管及董事的增持通常被视为对公司前景的信心信号，可能会对公司股价产生积极影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Form 4 | Pasithea Therapeutics Corp.董事 Lawrence Steinman 增持133,333股","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KTTA"],"gpt_icon":0},{"id":"2586228903","title":"Sutro Biopharma, Inc.盘中异动 临近收盘股价大涨5.23%报0.905美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586228903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586228903?lang=zh_cn&edition=full","pubTime":"2025-11-27 04:58","pubTimestamp":1764190719,"startTime":"0","endTime":"0","summary":"北京时间2025年11月27日04时58分，Sutro Biopharma, Inc.股票出现异动，股价快速上涨5.23%。截至发稿，该股报0.905美元/股，成交量47.4418万股，换手率0.56%，振幅8.45%。Sutro Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Sutro Biopharma, Inc.公司简介：Sutro Biopharma Inc 一家临床阶段药物发现、开发和制造公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127045840a7139f2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127045840a7139f2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","STRO","BK4139"],"gpt_icon":0},{"id":"2586403261","title":"Novabay Pharmaceuticals, Inc.盘中异动 股价大涨5.30%报0.990美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586403261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586403261?lang=zh_cn&edition=full","pubTime":"2025-11-27 01:15","pubTimestamp":1764177340,"startTime":"0","endTime":"0","summary":"北京时间2025年11月27日01时15分，Novabay Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.30%。截至发稿，该股报0.990美元/股，成交量8.6234万股，换手率0.07%，振幅6.91%。Novabay Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Novabay Pharmaceuticals, Inc.公司简介：NovaBay Pharmaceuticals Inc是一家生物制药公司，开发和销售科学创造和临床眼部护理,伤口护理和皮肤护理产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127011541951c0944&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127011541951c0944&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","KTTA","BK4139","NBY"],"gpt_icon":0},{"id":"2586267933","title":"Maia Biotechnology, Inc.盘中异动 早盘股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586267933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586267933?lang=zh_cn&edition=full","pubTime":"2025-11-26 23:11","pubTimestamp":1764169894,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日23时11分，Maia Biotechnology, Inc.股票出现异动，股价大幅上涨5.16%。Maia Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Scisparc Ltd.、Pasithea Therapeutics Corp.、Kala Bio, Inc.较为活跃，换手率分别为2436.49%、430.58%、179.75%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为272.65%、170.86%、49.76%。Maia Biotechnology, Inc.公司简介：MAIA Biotechnology Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126231134a7134195&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126231134a7134195&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MAIA","BK4139","KTTA"],"gpt_icon":0},{"id":"1167809601","title":"Pasithea Therapeutics获得ALS协会100万美元资金，研究Pas-004在治疗ALS中的疗效、安全性和耐受性","url":"https://stock-news.laohu8.com/highlight/detail?id=1167809601","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167809601?lang=zh_cn&edition=full","pubTime":"2025-11-25 20:02","pubTimestamp":1764072154,"startTime":"0","endTime":"0","summary":"Pasithea Therapeutics获得ALS协会100万美元资金，用于研究Pas-004在治疗肌萎缩侧索硬化症（ALS）中的疗效、安全性和耐受性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KTTAW","BK4139","KTTA"],"gpt_icon":0},{"id":"1111694989","title":"Pasithea Therapeutics宣布在晚期癌症患者中完成Pas-004的第7组阶段I临床试验，取得积极的安全性、药代动力学（Pk）和药效动力学（Pd）数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1111694989","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111694989?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:02","pubTimestamp":1763985763,"startTime":"0","endTime":"0","summary":"Pasithea Therapeutics宣布在晚期癌症患者中完成Pas-004的第7组阶段I临床试验，取得积极的安全性、药代动力学（Pk）和药效动力学（Pd）数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KTTA","KTTAW","BK4139"],"gpt_icon":0},{"id":"1134137576","title":"Pasithea Therapeutics Corp -第七组（37毫克胶囊）DLT期内未观察到与治疗相关的不良事件","url":"https://stock-news.laohu8.com/highlight/detail?id=1134137576","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134137576?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:02","pubTimestamp":1763985761,"startTime":"0","endTime":"0","summary":"Pasithea Therapeutics Corp -第七组（37毫克胶囊）DLT期内未观察到与治疗相关的不良事件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KTTA"],"gpt_icon":0},{"id":"1179978808","title":"Pasithea Therapeutics公布在成人NF1患者中进行的1/1B期试验中Pas-004片剂的积极药代动力学（Pk）数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1179978808","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179978808?lang=zh_cn&edition=full","pubTime":"2025-11-22 01:35","pubTimestamp":1763746513,"startTime":"0","endTime":"0","summary":"Pasithea Therapeutics公布在成人NF1患者中进行的1/1B期试验中Pas-004片剂的积极药代动力学（Pk）数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KTTA","KTTAW","BK4139"],"gpt_icon":0},{"id":"1122423961","title":"Pasithea Therapeutics发布积极的1期数据，包括部分缓解，显示Pas-004在晚期癌症研究中的单药临床活性和良好的安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=1122423961","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122423961?lang=zh_cn&edition=full","pubTime":"2025-11-21 05:02","pubTimestamp":1763672533,"startTime":"0","endTime":"0","summary":"Pasithea Therapeutics发布积极的1期数据，包括部分缓解，显示Pas-004在晚期癌症研究中的单药临床活性和良好的安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KTTA"],"gpt_icon":0},{"id":"1122325511","title":"Pasithea Therapeutics Corp：Pas-004 的耐受性良好，所有相关不良事件均为1级或2级","url":"https://stock-news.laohu8.com/highlight/detail?id=1122325511","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122325511?lang=zh_cn&edition=full","pubTime":"2025-11-21 05:02","pubTimestamp":1763672530,"startTime":"0","endTime":"0","summary":"Pasithea Therapeutics Corp：Pas-004 的耐受性良好，所有相关不良事件均为1级或2级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KTTA"],"gpt_icon":0},{"id":"2572227551","title":"Pasithea Therapeutics Corp.盘中异动 下午盘股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572227551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572227551?lang=zh_cn&edition=full","pubTime":"2025-10-02 01:07","pubTimestamp":1759338451,"startTime":"0","endTime":"0","summary":"北京时间2025年10月02日01时07分，Pasithea Therapeutics Corp.股票出现波动，股价大幅上涨5.22%。截至发稿，该股报0.770美元/股，成交量7.324万股，换手率0.98%，振幅5.68%。Pasithea Therapeutics Corp.股票所在的生物技术行业中，整体涨幅为2.83%。其相关个股中，Palisade Bio, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Larimar Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Aspire Biopharma Holdings, Inc.、Kala Bio, Inc.较为活跃，换手率分别为1442.84%、194.34%、35.84%，振幅较大的相关个股有Palisade Bio, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为98.51%、80.00%、69.37%。Pasithea Therapeutics Corp.公司简介：Pasithea Therapeutics Corp是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002010731a6aa314d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002010731a6aa314d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","LENZ","KTTA"],"gpt_icon":0},{"id":"1126813537","title":"Pasithea Therapeutics Corp.宣布在韩国启动Pas-004治疗成人NF1患者的1/1B期临床试验点","url":"https://stock-news.laohu8.com/highlight/detail?id=1126813537","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126813537?lang=zh_cn&edition=full","pubTime":"2025-09-16 19:03","pubTimestamp":1758020605,"startTime":"0","endTime":"0","summary":"Pasithea Therapeutics Corp.宣布在韩国启动临床试验点，用于开展Pas-004药物治疗成人NF1患者的1/1B期临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KTTAW","KTTA"],"gpt_icon":0},{"id":"2518205086","title":"Pasithea Therapeutics Corp.盘中异动 大幅下跌9.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518205086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518205086?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:39","pubTimestamp":1741628391,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时39分，Pasithea Therapeutics Corp.股票出现波动，股价急速下挫9.24%。截至发稿，该股报1.08美元/股，成交量7371股，换手率0.58%，振幅3.84%。Pasithea Therapeutics Corp.股票所在的生物技术行业中，整体涨幅为0.87%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为5288.34%、3824.05%、989.31%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、58.34%。Pasithea Therapeutics Corp.公司简介：Pasithea Therapeutics Corp 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031101395296406773&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031101395296406773&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KTTA"],"gpt_icon":0},{"id":"2517974591","title":"Pasithea Therapeutics Corp.盘中异动 下午盘急速下跌7.14%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517974591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517974591?lang=zh_cn&edition=full","pubTime":"2025-03-07 04:18","pubTimestamp":1741292296,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日04时18分，Pasithea Therapeutics Corp.股票出现异动，股价急速下跌7.14%。截至发稿，该股报1.17美元/股，成交量1.1446万股，换手率0.90%，振幅2.38%。Pasithea Therapeutics Corp.股票所在的生物技术行业中，整体跌幅为1.11%。Pasithea Therapeutics Corp.公司简介：Pasithea Therapeutics Corp 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307041816963c8861&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307041816963c8861&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KTTA"],"gpt_icon":0},{"id":"2517692884","title":"Pasithea Therapeutics Corp.盘中异动 急速拉升9.26%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517692884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517692884?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:10","pubTimestamp":1741198202,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时10分，Pasithea Therapeutics Corp.股票出现异动，股价急速拉升9.26%。截至发稿，该股报1.18美元/股，成交量9.0355万股，换手率7.13%，振幅12.96%。Pasithea Therapeutics Corp.股票所在的生物技术行业中，整体涨幅为1.34%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为946.41%、305.29%、300.32%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.，振幅分别为82.59%、54.27%、47.22%。Pasithea Therapeutics Corp.公司简介：Pasithea Therapeutics Corp 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021002abe9ef7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021002abe9ef7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","BK4139","LENZ"],"gpt_icon":0},{"id":"2516665617","title":"Pasithea Therapeutics Corp.盘中异动 股价大跌5.17%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516665617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516665617?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:00","pubTimestamp":1741035659,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日05时00分，Pasithea Therapeutics Corp.股票出现异动，股价急速下挫5.17%。截至发稿，该股报1.10美元/股，成交量3.5017万股，换手率2.77%，振幅6.22%。Pasithea Therapeutics Corp.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4718.81%、220.92%、191.83%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Pasithea Therapeutics Corp.公司简介：Pasithea Therapeutics Corp 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304050059963802d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304050059963802d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","BK4139","LENZ"],"gpt_icon":0},{"id":"2514336386","title":"Pasithea Therapeutics Corp.盘中异动 下午盘股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514336386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514336386?lang=zh_cn&edition=full","pubTime":"2025-02-28 02:11","pubTimestamp":1740679887,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日02时11分，Pasithea Therapeutics Corp.股票出现异动，股价快速跳水5.41%。截至发稿，该股报1.22美元/股，成交量1.9906万股，换手率1.57%，振幅3.01%。Pasithea Therapeutics Corp.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Pepgen Inc.、Cingulate Inc C/Wts 10/12/2026 、Ibio, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1759.85%、309.62%、131.27%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Pepgen Inc.，振幅分别为86.14%、55.19%、52.29%。Pasithea Therapeutics Corp.公司简介：Pasithea Therapeutics Corp 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280211279632db6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280211279632db6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KTTA"],"gpt_icon":0},{"id":"2514847865","title":"Pasithea Therapeutics Corp.盘中异动 股价大涨5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514847865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514847865?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:26","pubTimestamp":1740590789,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日01时26分，Pasithea Therapeutics Corp.股票出现异动，股价急速拉升5.65%。截至发稿，该股报1.22美元/股，成交量4.0598万股，换手率3.21%，振幅5.22%。Pasithea Therapeutics Corp.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Renovaro Inc.涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6122.39%、233.09%、223.02%，振幅较大的相关个股有Enveric Biosciences, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Pds Biotechnology Corporation，振幅分别为194.07%、49.18%、44.44%。Pasithea Therapeutics Corp.公司简介：Pasithea Therapeutics Corp 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022701262996316fd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022701262996316fd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KTTA"],"gpt_icon":0},{"id":"2514019090","title":"Pasithea Therapeutics Corp.盘中异动 早盘股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514019090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514019090?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:11","pubTimestamp":1740499893,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时11分，Pasithea Therapeutics Corp.股票出现波动，股价急速跳水5.56%。截至发稿，该股报1.19美元/股，成交量3.1777万股，换手率2.51%，振幅3.17%。Pasithea Therapeutics Corp.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1269.33%、1103.05%、869.48%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Adial Pharmaceuticals, Inc，振幅分别为224.93%、87.83%、64.05%。Pasithea Therapeutics Corp.公司简介：Pasithea Therapeutics Corp 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001133a2539dff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001133a2539dff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KTTA"],"gpt_icon":0},{"id":"2514761657","title":"Pasithea Therapeutics Corp.盘中异动 股价大跌6.15%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514761657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514761657?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:50","pubTimestamp":1740412229,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时50分，Pasithea Therapeutics Corp.股票出现异动，股价大幅跳水6.15%。截至发稿，该股报1.22美元/股，成交量13.0879万股，换手率10.33%，振幅6.92%。Pasithea Therapeutics Corp.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为231.75%、98.54%、28.36%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为151.09%、55.69%、53.34%。Pasithea Therapeutics Corp.公司简介：Pasithea Therapeutics Corp 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224235029962eab26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224235029962eab26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KTTA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pasithea.com","stockEarnings":[{"period":"1week","weight":0.0943},{"period":"1month","weight":0.5104},{"period":"3month","weight":0.468},{"period":"6month","weight":0.3096},{"period":"1year","weight":-0.6014},{"period":"ytd","weight":-0.6317}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0574},{"period":"6month","weight":0.1423},{"period":"1year","weight":0.1263},{"period":"ytd","weight":0.1677}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Pasithea Therapeutics Corp.于2020年5月12日在特拉华州成立。该公司从事有关CNS疾病的精神病学和神经病学研究，目标是将该研究转化为可用于临床的药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.144911},{"month":2,"riseRate":0.25,"avgChangeRate":-0.196749},{"month":3,"riseRate":0.5,"avgChangeRate":0.020643},{"month":4,"riseRate":0.25,"avgChangeRate":0.021877},{"month":5,"riseRate":0.25,"avgChangeRate":-0.227944},{"month":6,"riseRate":0.5,"avgChangeRate":0.06208},{"month":7,"riseRate":1,"avgChangeRate":0.10295},{"month":8,"riseRate":0.5,"avgChangeRate":-0.003687},{"month":9,"riseRate":0.5,"avgChangeRate":-0.003936},{"month":10,"riseRate":0.2,"avgChangeRate":-0.132455},{"month":11,"riseRate":0.4,"avgChangeRate":0.147256},{"month":12,"riseRate":0.4,"avgChangeRate":-0.183628}],"exchange":"NASDAQ","name":"Pasithea Therapeutics Corp.","nameEN":"Pasithea Therapeutics Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pasithea Therapeutics Corp.(KTTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Pasithea Therapeutics Corp.(KTTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Pasithea Therapeutics Corp.,KTTA,Pasithea Therapeutics Corp.股票,Pasithea Therapeutics Corp.股票老虎,Pasithea Therapeutics Corp.股票老虎国际,Pasithea Therapeutics Corp.行情,Pasithea Therapeutics Corp.股票行情,Pasithea Therapeutics Corp.股价,Pasithea Therapeutics Corp.股市,Pasithea Therapeutics Corp.股票价格,Pasithea Therapeutics Corp.股票交易,Pasithea Therapeutics Corp.股票购买,Pasithea Therapeutics Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pasithea Therapeutics Corp.(KTTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Pasithea Therapeutics Corp.(KTTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}